LFST logo

LifeStance Health (LFST) EBITDA

annual EBITDA:

$39.87M+$144.80M(+138.00%)
December 31, 2024

Summary

  • As of today (May 22, 2025), LFST annual EBITDA is $39.87 million, with the most recent change of +$144.80 million (+138.00%) on December 31, 2024.
  • During the last 3 years, LFST annual EBITDA has risen by +$279.93 million (+116.61%).
  • LFST annual EBITDA is now at all-time high.

Performance

1-year change

+138%

3-year change

+116.61%

5-year change

+105.75%

15-year change

+105.75%

LFST EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

84.06%
LFST annual EBITDA is higher than 84.06% of companies in Healthcare sector

Range

All-time high

$39.87M
LFST annual EBITDA is currently at an all-time high

3-year low

-$240.06M

Earnings dates

Last annual earnings report date

Dec 31, 2024
LFST previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
LFST next annual earnings announcement has not yet been scheduled

OtherLFSTincome statement metrics

Annual revenue

$1.25B
LFST annual revenue is $1.25 billion

annual net income

-$57.44M
LFST annual net profit is -$57.44 million

annual EBIT

-$31.08M
LFST annual earnings before interest & taxes is -$31.08 million

Annual EPS

-$0.15
LFST annual earnings per share is -$0.15

quarterly EBITDA:

$15.36M+$168.00K(+1.11%)
March 31, 2025

Summary

  • As of today (May 22, 2025), LFST quarterly EBITDA is $15.36 million, with the most recent change of +$168.00 thousand (+1.11%) on March 31, 2025.
  • Over the past year, LFST quarterly EBITDA has increased by +$7.63 million (+98.62%).
  • LFST quarterly EBITDA is now at all-time high.

Performance

3-month change

+1.11%

1-year change

+98.62%

3-year change

+130.79%

5-year change

+112.99%

LFST quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

82.62%
LFST quarterly EBITDA is higher than 82.62% of companies in Healthcare sector

Range

All-time high

$15.36M
LFST quarterly EBITDA is currently at an all-time high

3-year low

-$52.87M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
LFST previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 8, 2025
LFST next earnings announcement is scheduled for Aug 8, 2025

OtherLFSTincome statement metrics

Quarterly revenue

$332.97M
LFST quarterly revenue is $332.97 million

quarterly net income

$709.00K
LFST quarterly net profit is $709.00 thousand

quarterly EBIT

$1.60M
LFST quarterly earnings before interest & taxes is $1.60 million

Quarterly EPS

$0.00
LFST quarterly earnings per share is $0.00

TTM EBITDA:

$47.50M+$7.63M(+19.13%)
March 31, 2025

Summary

  • As of today (May 22, 2025), LFST TTM EBITDA is $47.50 million, with the most recent change of +$7.63 million (+19.13%) on March 31, 2025.
  • Over the past year, LFST TTM EBITDA has increased by +$130.57 million (+157.17%).
  • LFST TTM EBITDA is now at all-time high.

Performance

3-month change

+19.13%

1-year change

+157.17%

3-year change

+115.87%

5-year change

+558.69%

LFST TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

83.73%
LFST TTM EBITDA is higher than 83.73% of companies in Healthcare sector

Range

All-time high

$47.50M
LFST TTM EBITDA is currently at an all-time high

3-year low

-$305.41M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
LFST previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 8, 2025
LFST next earnings announcement is scheduled for Aug 8, 2025

OtherLFSTincome statement metrics

TTM revenue

$1.28B
LFST TTM revenue is $1.28 billion

TTM net income

-$35.64M
LFST TTM net profit is -$35.64 million

TTM EBIT

-$14.64M
LFST TTM earnings before interest & taxes is -$14.64 million

TTM EPS

-$0.10
LFST TTM earnings per share is -$0.10

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$39.87M
LFST annual EBITDA is $39.87 million

annual net income

-$57.44M
LFST annual net profit is -$57.44 million

annual interest expense

$26.54M
LFST annual interest expense is $26.54 million

annual income tax

-$170.00K
LFST annual income tax is -$170.00 thousand

annual D&A

$70.95M
LFST annual depreciation & amortization is $70.95 million

LFST EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+138.0%+98.6%+157.2%
3 y3 years+116.6%+130.8%+115.9%
5 y5 years+105.8%+113.0%+558.7%

LFST EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+116.6%at high+129.1%at high+115.5%
5 y5-yearat high+116.6%at high+113.7%at high+115.5%
alltimeall timeat high+116.6%at high+113.7%at high+115.5%

LFST EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$15.36M(+1.1%)
$47.50M(+19.1%)
Dec 2024
$39.87M(-138.0%)
$15.19M(+0.3%)
$39.87M(+182.5%)
Sep 2024
-
$15.15M(+740.5%)
$14.11M(-126.2%)
Jun 2024
-
$1.80M(-76.7%)
-$53.90M(-35.1%)
Mar 2024
-
$7.73M(-173.2%)
-$83.08M(-20.8%)
Dec 2023
-$104.93M(-26.9%)
-$10.57M(-80.0%)
-$104.93M(-15.4%)
Sep 2023
-
-$52.87M(+93.2%)
-$124.02M(+35.9%)
Jun 2023
-
-$27.37M(+93.9%)
-$91.29M(-15.4%)
Mar 2023
-
-$14.12M(-52.4%)
-$107.84M(-24.9%)
Dec 2022
-$143.60M
-$29.66M(+47.3%)
-$143.60M(-32.8%)
Sep 2022
-
-$20.13M(-54.2%)
-$213.62M(-30.1%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$43.93M(-11.9%)
-$305.41M(+2.0%)
Mar 2022
-
-$49.88M(-50.0%)
-$299.35M(+24.7%)
Dec 2021
-$240.06M(-1338.8%)
-$99.68M(-10.9%)
-$240.06M(+86.2%)
Sep 2021
-
-$111.92M(+195.5%)
-$128.95M(+3073.7%)
Jun 2021
-
-$37.87M(-502.2%)
-$4.06M(-110.4%)
Mar 2021
-
$9.42M(-17.6%)
$39.09M(+6.0%)
Dec 2020
-
$11.43M(-11.8%)
$36.89M(+44.9%)
Sep 2020
-
$12.96M(+145.4%)
$25.46M(+103.8%)
Jun 2020
-
$5.28M(-26.8%)
$12.49M(+73.2%)
Mar 2020
-
$7.21M
$7.21M
Dec 2019
$19.38M
-
-

FAQ

  • What is LifeStance Health annual EBITDA?
  • What is the all time high annual EBITDA for LifeStance Health?
  • What is LifeStance Health annual EBITDA year-on-year change?
  • What is LifeStance Health quarterly EBITDA?
  • What is the all time high quarterly EBITDA for LifeStance Health?
  • What is LifeStance Health quarterly EBITDA year-on-year change?
  • What is LifeStance Health TTM EBITDA?
  • What is the all time high TTM EBITDA for LifeStance Health?
  • What is LifeStance Health TTM EBITDA year-on-year change?

What is LifeStance Health annual EBITDA?

The current annual EBITDA of LFST is $39.87M

What is the all time high annual EBITDA for LifeStance Health?

LifeStance Health all-time high annual EBITDA is $39.87M

What is LifeStance Health annual EBITDA year-on-year change?

Over the past year, LFST annual EBITDA has changed by +$144.80M (+138.00%)

What is LifeStance Health quarterly EBITDA?

The current quarterly EBITDA of LFST is $15.36M

What is the all time high quarterly EBITDA for LifeStance Health?

LifeStance Health all-time high quarterly EBITDA is $15.36M

What is LifeStance Health quarterly EBITDA year-on-year change?

Over the past year, LFST quarterly EBITDA has changed by +$7.63M (+98.62%)

What is LifeStance Health TTM EBITDA?

The current TTM EBITDA of LFST is $47.50M

What is the all time high TTM EBITDA for LifeStance Health?

LifeStance Health all-time high TTM EBITDA is $47.50M

What is LifeStance Health TTM EBITDA year-on-year change?

Over the past year, LFST TTM EBITDA has changed by +$130.57M (+157.17%)
On this page